Home › Arena- Belviq Sales Continue To Under-Perform And Underwhelm
 

Keywords :   


Arena- Belviq Sales Continue To Under-Perform And Underwhelm

2016-02-17 05:30:31| Biotech - Topix.net

Arena saw U.S. sales of Belviq continue to under-perform levels needed to impress the street this past week. Sales are 12% off of the pace established in Q4, and are down a stunning 22% from the levels we were seeing just a year ago.

Tags: sales continue arena underperform

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
10.05UK emerged from recession at start of year
10.05UK economy out of recession, official figures show
10.05Rat remains found in bread sparks Japan recall and refunds
10.05Argentines strike against spending cuts
10.05Argentines strike against spending cuts
10.05Two Daytona Waste Pro Drivers Jump into Action After Car Crash
10.05Together for Safer Roads and National Waste & Recycling Association Announce New Participants in FOCUS on Fleet Safety Training
10.05Start Your Day with Tom Gratz, Sales Manager USA, Hitachi Zosen Inova
More »